Thurston, Springer, Miller, Herd & Titak, Inc. Amgen Inc Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $475 Million
- Q4 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 7,585 shares of AMGN stock, worth $2.19 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
7,585
Previous 5,438
39.48%
Holding current value
$2.19 Million
Previous $1.75 Million
12.79%
% of portfolio
0.42%
Previous 0.53%
Shares
4 transactions
Others Institutions Holding AMGN
# of Institutions
3,083Shares Held
401MCall Options Held
7.57MPut Options Held
7.16M-
Vanguard Group Inc Valley Forge, PA52.4MShares$15.1 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.3 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.47 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.24 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$4.12 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $155B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...